From the Desk of Steve Strazza and Alfonso Depablos
Cathie Wood’s ARK Investment Management is on our list today, as it just filed multiple 13G filings on the following stocks:
- Teladoc Health, Inc $TDOC, increasing its ownership stake from 11.43% to 12.82%;
- Intellia Therapeutics, Inc $NTLA, increasing its ownership stake from 10.52% to 12.74%;
- Recursion Pharmaceuticals, Inc $RXRX, initiating a 9.92% stake;
- Verve Therapeutics, Inc $VERV, increasing its ownership stake from 5.43% to 8.84%;
- Ginkgo Bioworks Holdings, Inc $DNA, increasing its ownership stake from 8.92% to 12.26%; and
- Twist Bioscience Corp $TWST, increasing its ownership stake from 11.60% to 12.51%.
Here’s The Hot Corner, with data through January 29, 2024:
RA Capital Management filed a 13D for Edgewise Therapeutics $EWTX increasing its ownership stake from 2.85% to 9.60%.
There was no unusual options activity to report.
Stay tuned. We’ll be back on Wednesday with more insider activity.
To have these insider transactions e-mailed to you every morning, sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team